Search

Agnieszka Boesen

Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1671, 1672, 1648
Total Applications
1050
Issued Applications
614
Pending Applications
117
Abandoned Applications
353

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5236053 [patent_doc_number] => 20070128209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'VACCINE BASED METHOD FOR PROTECTION AGAINST HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 11/309193 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4012 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128209.pdf [firstpage_image] =>[orig_patent_app_number] => 11309193 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/309193
VACCINE BASED METHOD FOR PROTECTION AGAINST HIV INFECTION Jul 11, 2006 Abandoned
Array ( [id] => 4711975 [patent_doc_number] => 20080300501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Fluid Analyser' [patent_app_type] => utility [patent_app_number] => 11/995698 [patent_app_country] => US [patent_app_date] => 2006-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2268 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300501.pdf [firstpage_image] =>[orig_patent_app_number] => 11995698 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/995698
Fluid Analyser Jul 5, 2006 Abandoned
Array ( [id] => 5580556 [patent_doc_number] => 20090175902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Immunogenic Substances Comprising A Polyinosinic Acid-Polycytidilic Acid Based Adjuvant' [patent_app_type] => utility [patent_app_number] => 12/160583 [patent_app_country] => US [patent_app_date] => 2006-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 23646 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175902.pdf [firstpage_image] =>[orig_patent_app_number] => 12160583 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/160583
Immunogenic Substances Comprising A Polyinosinic Acid-Polycytidilic Acid Based Adjuvant Jun 26, 2006 Abandoned
Array ( [id] => 5367179 [patent_doc_number] => 20090304738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Methods for Enhancing Immune Responses' [patent_app_type] => utility [patent_app_number] => 11/922427 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 31530 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304738.pdf [firstpage_image] =>[orig_patent_app_number] => 11922427 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/922427
Methods for Enhancing Immune Responses Jun 14, 2006 Abandoned
Array ( [id] => 8548330 [patent_doc_number] => 08323207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Method and device for measurement of exhaled respiratory gas temperature' [patent_app_type] => utility [patent_app_number] => 11/996963 [patent_app_country] => US [patent_app_date] => 2006-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4677 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11996963 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/996963
Method and device for measurement of exhaled respiratory gas temperature Jun 11, 2006 Issued
Array ( [id] => 5887725 [patent_doc_number] => 20060275323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Particles of HCV envelope proteins: use for vaccination' [patent_app_type] => utility [patent_app_number] => 11/445274 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 17639 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275323.pdf [firstpage_image] =>[orig_patent_app_number] => 11445274 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/445274
Particles of HCV envelope proteins: use for vaccination Jun 1, 2006 Abandoned
Array ( [id] => 4959718 [patent_doc_number] => 20080274143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Chloroplasts Engineering to Express Pharmaceutical Proteins' [patent_app_type] => utility [patent_app_number] => 11/915666 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 66288 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274143.pdf [firstpage_image] =>[orig_patent_app_number] => 11915666 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/915666
Chloroplasts Engineering to Express Pharmaceutical Proteins May 29, 2006 Abandoned
Array ( [id] => 836851 [patent_doc_number] => 07393666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis' [patent_app_type] => utility [patent_app_number] => 11/440177 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22831 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393666.pdf [firstpage_image] =>[orig_patent_app_number] => 11440177 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/440177
Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis May 23, 2006 Issued
Array ( [id] => 5538738 [patent_doc_number] => 20090220543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Expression of Proteins in Plants' [patent_app_type] => utility [patent_app_number] => 11/912912 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11078 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220543.pdf [firstpage_image] =>[orig_patent_app_number] => 11912912 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/912912
Expression of proteins in plants May 1, 2006 Issued
Array ( [id] => 5538738 [patent_doc_number] => 20090220543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Expression of Proteins in Plants' [patent_app_type] => utility [patent_app_number] => 11/912912 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11078 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220543.pdf [firstpage_image] =>[orig_patent_app_number] => 11912912 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/912912
Expression of proteins in plants May 1, 2006 Issued
Array ( [id] => 5270890 [patent_doc_number] => 20090074666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Peptide vaccine for influenza virus' [patent_app_type] => utility [patent_app_number] => 11/918791 [patent_app_country] => US [patent_app_date] => 2006-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 26446 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074666.pdf [firstpage_image] =>[orig_patent_app_number] => 11918791 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/918791
Peptide vaccine for influenza virus Apr 19, 2006 Abandoned
Array ( [id] => 5508429 [patent_doc_number] => 20090081636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Pharmaceutical compositions for and methods of inhibiting HCV replication' [patent_app_type] => utility [patent_app_number] => 11/401408 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 92062 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081636.pdf [firstpage_image] =>[orig_patent_app_number] => 11401408 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/401408
Pharmaceutical compositions for and methods of inhibiting HCV replication Apr 10, 2006 Abandoned
Array ( [id] => 4728216 [patent_doc_number] => 20080207760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Pharmaceutical Compositions For and Methods of Inhibiting Hcv' [patent_app_type] => utility [patent_app_number] => 11/911330 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 92416 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207760.pdf [firstpage_image] =>[orig_patent_app_number] => 11911330 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/911330
Pharmaceutical Compositions For and Methods of Inhibiting Hcv Apr 10, 2006 Abandoned
Array ( [id] => 10001648 [patent_doc_number] => 09045727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Virus-like particles, methods of preparation, and immunogenic compositions' [patent_app_type] => utility [patent_app_number] => 11/397830 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 23357 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11397830 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/397830
Virus-like particles, methods of preparation, and immunogenic compositions Apr 3, 2006 Issued
Array ( [id] => 4845503 [patent_doc_number] => 20080181911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Use Of An Influenza Virus, An Oil-In-Water Emulsion Adjuvant, To Induce Cd4 T-Cell And/Or Improved B-Memory Cell Response' [patent_app_type] => utility [patent_app_number] => 11/909351 [patent_app_country] => US [patent_app_date] => 2006-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 47779 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181911.pdf [firstpage_image] =>[orig_patent_app_number] => 11909351 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/909351
Use Of An Influenza Virus, An Oil-In-Water Emulsion Adjuvant, To Induce Cd4 T-Cell And/Or Improved B-Memory Cell Response Mar 20, 2006 Abandoned
Array ( [id] => 4921917 [patent_doc_number] => 20080070232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Expression Vectors Containing a Truncated Epstein Barr Nuclear Antigen 1 Lacking the Gly-Gly-Ala Domain for Enhanced Transient Gene Expression' [patent_app_type] => utility [patent_app_number] => 11/576005 [patent_app_country] => US [patent_app_date] => 2005-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 2886 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070232.pdf [firstpage_image] =>[orig_patent_app_number] => 11576005 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576005
Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression Mar 16, 2006 Issued
Array ( [id] => 5760067 [patent_doc_number] => 20060211012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'MHC CLASS II AS A PREVENTIVE VACCINE AGAINST HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 11/307951 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2061 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211012.pdf [firstpage_image] =>[orig_patent_app_number] => 11307951 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/307951
MHC CLASS II AS A PREVENTIVE VACCINE AGAINST HIV INFECTION Feb 27, 2006 Abandoned
Array ( [id] => 8213314 [patent_doc_number] => 08192747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Live attenuated rotavirus vaccine for oral administration' [patent_app_type] => utility [patent_app_number] => 11/816443 [patent_app_country] => US [patent_app_date] => 2006-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 32193 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/192/08192747.pdf [firstpage_image] =>[orig_patent_app_number] => 11816443 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/816443
Live attenuated rotavirus vaccine for oral administration Feb 14, 2006 Issued
Array ( [id] => 5337898 [patent_doc_number] => 20090054362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/816236 [patent_app_country] => US [patent_app_date] => 2006-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12018 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054362.pdf [firstpage_image] =>[orig_patent_app_number] => 11816236 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/816236
COMPOUNDS Feb 14, 2006 Abandoned
Array ( [id] => 5446075 [patent_doc_number] => 20090047301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Papillomavirus L2 N-Terminal Peptides for the Induction of Broadly Cross-Neutralizing Antibodies' [patent_app_type] => utility [patent_app_number] => 11/883495 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 59572 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047301.pdf [firstpage_image] =>[orig_patent_app_number] => 11883495 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/883495
Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies Jan 31, 2006 Issued
Menu